Bär & Karrer Successfully Represents PNK Group Company in SCAI-Arbitration
Bär & Karrer successfully represented a company acting under the trademark of PNK Group, a major developer of industrial facilities in Russia, against a Western European concrete plant engineering and manufacturing company in a SCAI-arbitration concerning the delivery of (defective) equipment. After full-fledged proceedings including a hearing with several technical experts, the client was awarded …
Continue reading “Bär & Karrer Successfully Represents PNK Group Company in SCAI-Arbitration”
Bär & Karrer Advises Zurich on its Investment in autoSense
Zurich Insurance Company Ltd (Zurich) invests in the Swiss start-up autoSense. Zurich will further develop autoSense's business together with Swisscom and Amag. autoSense operates a digital service portal which connects vehicles through an app and provides real-time information and services to car owners.
Bär & Karrer Advises Swedish Orphan Biovitrum AB in the Acquisition of emapalumab
Swedish Orphan Biovitrum AB, an international specialty biopharmaceutical company listed in Sweden, agreed to acquire, from Novimmune’s shareholders, a newly established company owning emapalumab and related assets, giving Sobi access to world-class R&D capabilities in the field of Immunology. The acquisition supersedes the previously announced exclusive licence agreement with Novimmune. In addition, Sobi agreed with …
Continue reading “Bär & Karrer Advises Swedish Orphan Biovitrum AB in the Acquisition of emapalumab”
Bär & Karrer Advises Patinex and BZ Bank on the Sale of NovImmune to Light Chain Bioscicence
Light Chain Bioscience AG, a Swiss biotech company, agreed to purchase all shares in NovImmune SA, a company focused on the discovery and development of antibody-based drugs for the targeted treatment of inflammatory diseases, immune related disorders and cancer. Patinex and BZ Bank are the selling majority shareholders of NovImmune.
Bär & Karrer Awarded “Law Firm of the Year – Switzerland” at the Citywealth Magic Circle Awards 201
Bär & Karrer is pleased to announce that it has received the award “Law Firm of the Year – Switzerland” at the Citywealth Magic Circle Awards in London. This award recognizes Bär & Karrer as the Swiss law firm with the best private client team.
Bär & Karrer Advises Ashcroft on the Acquisition of Rüeger Holding
Ashcroft Inc., headquartered in Stratford, CT, USA, a subsidiary of Tokyo Stock Exchange listed Nagano Keiki Co., Ltd, has announced the completion of the acquisition of Swiss-based Rüeger Holding SA (Rüeger) and Dutch-based STIKO Meetapparentenfabriek B.V. (Stiko), both manufacturers of specialty temperature and pressure measurement products, from their previous owners, Bernard and Jean-Marc Rüeger.
Ordinance on Integrity and Transparency in the Therapeutic Products Sector has been adopted
Click here for more information.
Bär & Karrer Advises B3i in its Current Equity Funding Round
Industry-led InsurTech B3i Services AG successfully raised additional funds from current shareholders and new investors to further develop and grow its blockchain-based insurance transaction platform. B3i was founded in October 2016 as an insurance industry consortium which then formed B3i Services AG as an independent company. The shareholder group includes some of the world's largest …
Continue reading “Bär & Karrer Advises B3i in its Current Equity Funding Round”
Bär & Karrer Continues to Grow Finance and Sports Practice with Two New Partners
Bär &Karrer is pleased to announce that it further strengthens its Financing and Sports practices with new partners Lukas Roesler and Dr. Jan Kleiner, both of whom have worked with the firm previously.
Bär & Karrer Advises Novartis and Alcon on the Spin-off of Alcon
Today, Novartis AG completed the spin-off of the Alcon eye care devices business, and Alcon Inc. debuted as independent publicly traded company. The Alcon shares were successfully listed on the SIX Swiss Exchange Ltd. and the New York Stock Exchange. They are also included in the Swiss Market Index (SMI), which comprises the 20 largest …
Continue reading “Bär & Karrer Advises Novartis and Alcon on the Spin-off of Alcon”